Suchergebnisse - "Wang, Bi-Cheng"

PubPharm (230)

1

A rice GT61 glycosyltransferase possesses dual activities mediating 2-O-xylosyl and 2-O-arabinosyl substitutions of xylan

enthalten in: Planta | 2024

von Zhong, R. | Zhou, D. | Phillips, D. | +5

2

A rice GT61 glycosyltransferase possesses dual activities mediating 2-O-xylosyl and 2-O-arabinosyl substitutions of xylan

enthalten in: Planta | 2024

von Zhong, R. | Zhou, D. | Phillips, D. | +5

3

Lenvatinib Versus Atezolizumab Plus Bevacizumab in the First-Line Treatment for Unresectable Hepatocellular Carcinoma : A Meta-Analysis of Real-World Studies

enthalten in: Targeted oncology | 2024

von Wang, B. | Kuang, B. | Lin, G.

4

Safety and efficacy of pyrotinib for HER‑2‑positive breast cancer in the neoadjuvant setting : A systematic review and meta‑analysis

enthalten in: Oncology letters | 2024

von Ma, Q. | Wei, B. | Wang, B. | +3

5

Lenvatinib Versus Atezolizumab Plus Bevacizumab in the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Meta-Analysis of Real-World Studies

enthalten in: Targeted oncology | 2024

von Wang, B. | Kuang, B. | Lin, G.

6

Tyrosine kinase inhibitors in patients with advanced anaplastic thyroid cancer : an effective analysis based on real-world retrospective studies

enthalten in: Frontiers in endocrinology | 2024

von Kuang, B. | Zhang, W. | Lin, G. | +3

7

Novel-fosfamide monotherapy or in combination with doxorubicin versus doxorubicin alone in patients with advanced soft tissue sarcoma : A pooled analysis of randomized clinical trials

enthalten in: Medicine | 2023

von Liu, X. | Han, Y. | Kuang, B. | +2

8

An integrated analysis of Sacituzumab govitecan in relapsed or refractory metastatic triple-negative breast cancer

enthalten in: Medicine | 2023

von Cheng, S. | Chen, Q. | Lin, G. | +4

9

Treating radiation‑related nasopharyngeal necrosis with endostar in patient with nasopharyngeal carcinoma : A report of two cases and a literature review

enthalten in: Molecular and clinical oncology | 2023

von Tang, J. | Li, X. | Wu, Y. | +7

10

The efficacy of adebrelimab compared with durvalumab and atezolizumab in untreated extensive-stage small-cell lung cancer : a survival analysis of reconstructed patient-level data

enthalten in: Frontiers in immunology | 2023

von Wang, B. | Fu, C. | Lin, G.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[23]